If cancer is a disease of overabundance, where cells divide without restraint and tumors grow despite the body's best interests, then degenerative diseases are disorders of deprivation. When ...
When malfunctions occur in the biological machinery our muscles or our brains use for renewal and repairs, these tissues ...
WASHINGTON, Aug. 28, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for ...
Incyte Corp. has identified tyrosine-protein kinase JAK2 (V617F mutant) inhibitors reported to be useful for the treatment of cancer, hypereosinophilic syndrome, systemic mastocytosis and essential ...
Vanda Pharmaceuticals has won a key U.S. Food and Drug Administration designation for its proposed VGT-1849B treatment of the rare blood disease polycythemia vera. Vanda on Thursday said the FDA ...
Polycythemia vera is not hereditary. While it results from a genetic mutation, or a change in the DNA in a bone marrow cell, the change usually develops during life. It isn’t something you are born ...
WASHINGTON, Dec. 20, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback